Charles Schwab Investment Management Inc. Reduces Stock Position in ICU Medical, Inc. $ICUI

Charles Schwab Investment Management Inc. lessened its position in shares of ICU Medical, Inc. (NASDAQ:ICUI - Free Report) by 2.1% in the first quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 297,825 shares of the medical instruments supplier's stock after selling 6,330 shares during the period. Charles Schwab Investment Management Inc. owned 1.21% of ICU Medical worth $41,356,000 at the end of the most recent reporting period.

A number of other hedge funds have also bought and sold shares of the company. Dimensional Fund Advisors LP raised its stake in ICU Medical by 18.2% during the fourth quarter. Dimensional Fund Advisors LP now owns 539,981 shares of the medical instruments supplier's stock worth $83,788,000 after buying an additional 82,982 shares during the last quarter. Northern Trust Corp raised its stake in ICU Medical by 11.1% during the fourth quarter. Northern Trust Corp now owns 402,342 shares of the medical instruments supplier's stock worth $62,431,000 after buying an additional 40,187 shares during the last quarter. Point72 Asset Management L.P. increased its stake in ICU Medical by 63.2% in the fourth quarter. Point72 Asset Management L.P. now owns 245,340 shares of the medical instruments supplier's stock valued at $38,069,000 after purchasing an additional 95,030 shares in the last quarter. Oberweis Asset Management Inc. increased its stake in ICU Medical by 20.1% in the fourth quarter. Oberweis Asset Management Inc. now owns 156,680 shares of the medical instruments supplier's stock valued at $24,312,000 after purchasing an additional 26,180 shares in the last quarter. Finally, Victory Capital Management Inc. increased its stake in ICU Medical by 5.7% in the first quarter. Victory Capital Management Inc. now owns 149,246 shares of the medical instruments supplier's stock valued at $20,724,000 after purchasing an additional 8,101 shares in the last quarter. Institutional investors own 96.10% of the company's stock.

ICU Medical Stock Performance

Shares of ICU Medical stock traded up $5.6850 during mid-day trading on Friday, hitting $127.4350. 40,777 shares of the stock were exchanged, compared to its average volume of 266,997. The company has a 50-day simple moving average of $127.24 and a 200 day simple moving average of $137.28. The company has a market capitalization of $3.15 billion, a P/E ratio of -84.00 and a beta of 0.88. ICU Medical, Inc. has a 12 month low of $107.00 and a 12 month high of $196.26. The company has a debt-to-equity ratio of 0.63, a quick ratio of 1.17 and a current ratio of 2.44.

ICU Medical (NASDAQ:ICUI - Get Free Report) last issued its quarterly earnings results on Thursday, August 7th. The medical instruments supplier reported $2.10 EPS for the quarter, topping analysts' consensus estimates of $1.44 by $0.66. The business had revenue of $543.57 million for the quarter, compared to analyst estimates of $543.33 million. ICU Medical had a positive return on equity of 7.24% and a negative net margin of 1.56%.ICU Medical's quarterly revenue was down 8.0% compared to the same quarter last year. During the same period last year, the company posted $1.56 earnings per share. ICU Medical has set its FY 2025 guidance at 6.850-7.15 EPS. Sell-side analysts anticipate that ICU Medical, Inc. will post 4.11 earnings per share for the current fiscal year.

Analyst Ratings Changes

Several equities research analysts have weighed in on the stock. Wall Street Zen downgraded shares of ICU Medical from a "buy" rating to a "hold" rating in a research note on Saturday, August 9th. Raymond James Financial decreased their price target on shares of ICU Medical from $187.00 to $180.00 and set a "strong-buy" rating for the company in a research note on Friday, August 8th. Finally, Piper Sandler assumed coverage on shares of ICU Medical in a research note on Friday, August 15th. They issued an "overweight" rating and a $145.00 price target for the company. One research analyst has rated the stock with a Strong Buy rating, three have given a Buy rating and one has issued a Hold rating to the company's stock. According to MarketBeat.com, the stock currently has a consensus rating of "Buy" and an average price target of $179.00.

Insider Transactions at ICU Medical

In related news, CEO Vivek Jain bought 21,929 shares of the company's stock in a transaction on Thursday, August 14th. The shares were purchased at an average cost of $112.84 per share, for a total transaction of $2,474,468.36. Following the completion of the purchase, the chief executive officer directly owned 130,149 shares in the company, valued at $14,686,013.16. The trade was a 20.26% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the SEC, which is accessible through this link. Also, COO Christian B. Voigtlander sold 4,985 shares of the business's stock in a transaction dated Wednesday, May 28th. The shares were sold at an average price of $128.50, for a total transaction of $640,572.50. Following the completion of the transaction, the chief operating officer owned 6,088 shares in the company, valued at approximately $782,308. The trade was a 45.02% decrease in their ownership of the stock. The disclosure for this sale can be found here. 1.50% of the stock is owned by insiders.

About ICU Medical

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.